Ozempic vs Orlistat UK Prescription | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Ozempic vs Orlistat: Get Your UK Prescription Online

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW 10 % off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£145.00 From £135.00 10% discount using discount code WEIGHTLOSSNEW
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen - UK-licensed prescription Treatment
Treatment

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

From £145.00

Future orders save 5%
Start Assessment
Wegovy (Semaglutide) Weight Loss Injection - UK-licensed prescription Treatment
Treatment

Wegovy (Semaglutide) Weight Loss Injection

From £89.00

Future orders save 5%
Start Assessment
Saxenda - UK-licensed prescription Treatment
Treatment

Saxenda

From £68.00

Future orders save 5%
Start Assessment
Orlistat - UK-licensed prescription Treatment
Treatment

Orlistat

From £32.00

Future orders save 5%
Start Assessment
Xenical Orlistat 120mg Capsules - UK-licensed prescription Treatment
Treatment

Xenical Orlistat 120mg Capsules

From £49.99

Future orders save 5%
Start Assessment
Alli Weight Loss Capsules 60mg - UK-licensed prescription Treatment
Treatment

Alli Weight Loss Capsules 60mg

From £49.99

Future orders save 5%
Start Assessment

Ozempic vs Orlistat: Get Your UK Prescription Online

Published on: June 03, 2026

Choosing between ozempic vs orlistat uk prescription options depends on your weight loss goals, lifestyle, and medical history. At Cured Pharmacy, our UK-registered clinical team provides free online consultations to help you access the right treatment—whether that's injectable GLP-1 medications or oral fat-blocker tablets—with transparent pricing and discreet home delivery.

How Ozempic and Orlistat Work Differently

Ozempic (semaglutide) is a once-weekly injectable GLP-1 receptor agonist that mimics a natural gut hormone, slowing gastric emptying, reducing appetite, and improving blood sugar control [1]. Originally licensed for type 2 diabetes, semaglutide has demonstrated significant weight loss effects in clinical trials, with patients losing an average of 14.9% body weight over 68 weeks in the STEP 1 trial [2].

Orlistat, by contrast, is an oral lipase inhibitor taken three times daily with meals. It blocks approximately 30% of dietary fat absorption in the gut, reducing calorie intake from fat-rich foods [3]. Unlike GLP-1 treatments, Orlistat works locally in the digestive system and does not affect appetite hormones or blood sugar regulation.

The fundamental difference is mechanism: Ozempic addresses appetite and metabolic pathways centrally, whilst Orlistat prevents fat absorption peripherally. This distinction influences not only efficacy but also side effect profiles, dosing convenience, and suitability for different patient groups.

Ozempic vs Orlistat: Weight Loss Results Compared

Clinical trial data reveals substantial differences in weight loss magnitude. In the STEP programme, semaglutide 2.4mg (the dose used in Wegovy, Ozempic's weight loss formulation) produced average reductions of 14.9% total body weight over 68 weeks [2]. Patients on placebo lost just 2.4% during the same period.

Orlistat trials show more modest results. The XENDOS study demonstrated average weight loss of 5.8kg over one year in patients taking Orlistat 120mg three times daily, compared to 3.0kg with placebo—a difference of approximately 2.8kg [3]. Long-term studies suggest Orlistat users typically lose 5-10% of initial body weight when combined with calorie-controlled diets.

Whilst GLP-1 treatments generally produce greater absolute weight reduction, Orlistat remains clinically effective for patients seeking oral medication, those with contraindications to injectable treatments, or individuals who respond well to fat-reduction strategies. Your UK prescriber will assess which approach aligns with your medical profile and weight loss targets.

Realistic Expectations for Both Treatments

Neither medication guarantees specific outcomes—individual results vary based on adherence, dietary habits, physical activity, and metabolic factors. Clinical trials represent controlled conditions; real-world effectiveness depends heavily on lifestyle modifications alongside pharmacotherapy. Both treatments require commitment to dietary changes for optimal results.

Side Effects: What to Expect with Each Treatment

Ozempic's most common side effects are gastrointestinal: nausea (affecting up to 44% of patients in trials), vomiting, diarrhoea, and constipation [1]. These symptoms typically diminish over 4-8 weeks as the body adjusts. Rare but serious risks include pancreatitis, gallbladder disease, and potential thyroid concerns, which is why thorough medical screening is essential before starting treatment.

Orlistat's side effects relate directly to its fat-blocking mechanism. Patients may experience oily stools, faecal urgency, flatulence with discharge, and increased bowel movements—particularly when consuming high-fat meals [3]. These effects are dose-dependent and can be managed by reducing dietary fat intake to below 30% of total calories. Unlike GLP-1 treatments, Orlistat does not cause nausea or affect blood sugar directly.

Tolerability profiles differ markedly: Ozempic users often report appetite suppression as a therapeutic effect, whilst Orlistat users must actively modify fat intake to minimise gastrointestinal symptoms. Your UK prescriber will discuss your tolerance for injection-based versus oral therapies during consultation.

Managing Side Effects Effectively

For Ozempic, starting at lower doses and gradually titrating upwards reduces nausea risk. Eating smaller, more frequent meals and avoiding high-fat foods can further improve tolerability. With Orlistat, adherence to a low-fat diet (less than 15g fat per meal) significantly reduces gastrointestinal side effects. Both medications benefit from proactive dietary planning and regular follow-up with healthcare professionals.

Feature Ozempic (Semaglutide) Orlistat
Mechanism GLP-1 receptor agonist (appetite suppression) Lipase inhibitor (blocks fat absorption)
Administration Once-weekly injection Three times daily oral capsule
Average Weight Loss 14.9% body weight (68 weeks) 5-10% body weight (12 months)
Common Side Effects Nausea, vomiting, diarrhoea Oily stools, faecal urgency, flatulence
Starting Price at Cured Pharmacy From £69.00 (Wegovy) From £32
Dietary Requirements Calorie reduction recommended Low-fat diet essential (< 30% calories from fat)
Suitable For Higher BMI, diabetes, injection-tolerant patients Oral preference, budget-conscious, fat-reduction strategy

Dosing, Administration, and Lifestyle Considerations

Ozempic is administered via subcutaneous injection once weekly using a pre-filled pen device. Patients typically start at 0.25mg weekly for four weeks, then increase to 0.5mg, with potential escalation to 1mg or 2mg depending on response and tolerability [1]. The once-weekly schedule offers convenience for individuals who prefer minimal daily medication routines.

Orlistat requires three 120mg capsules daily, taken with each main meal containing fat (or up to one hour after eating). If a meal contains no fat, the dose can be skipped. This thrice-daily regimen demands consistent adherence and meal planning, which some patients find challenging compared to weekly injections. Lower-dose Orlistat (60mg) is available over-the-counter, though prescription-strength 120mg provides greater efficacy.

Lifestyle integration varies: Ozempic users must be comfortable with self-injection and managing potential nausea during initial weeks. Orlistat users need structured meal patterns and willingness to modify fat intake substantially. Neither medication works effectively without dietary changes—both are adjuncts to calorie reduction and increased physical activity, not standalone solutions.

Cost and Accessibility: Ozempic vs Orlistat UK Prescription Options

Orlistat is the most budget-friendly prescription weight loss option available at Cured Pharmacy, starting from £135.00 for generic formulations. Brand-name Xenical (Orlistat 120mg) and over-the-counter Alli (60mg) are also available, with transparent pricing displayed before consultation. This accessibility makes Orlistat particularly suitable for patients seeking effective treatment at lower cost points.

GLP-1 treatments represent a higher investment but offer greater average weight loss in clinical trials. Whilst Ozempic itself is primarily licensed for diabetes, similar semaglutide formulations for weight management are available at competitive UK pricing. Alternative GLP-1 options at Cured Pharmacy include Wegovy and Saxenda, with prices varying by dose and treatment duration.

All prescription medications at Cured Pharmacy require a free online consultation with a UK-registered prescriber, completed in under three minutes. Our transparent pricing model shows exact costs upfront—no hidden fees or surprise charges. Whether you're considering Orlistat or injectable alternatives, our clinical team will recommend the most appropriate and cost-effective option based on your individual assessment.

Insurance and NHS Availability

Orlistat may be prescribed on the NHS for patients with BMI ≥30 kg/m² (or ≥28 kg/m² with comorbidities), subject to local formulary restrictions and GP availability. GLP-1 treatments for weight management have limited NHS access due to budget constraints. Private prescription through registered UK pharmacies like Cured Pharmacy offers faster access and greater treatment choice, with clinical oversight ensuring safe, appropriate prescribing.

Which Treatment Is Right for You? Clinical Considerations

Orlistat suits patients who prefer oral medication, have contraindications to GLP-1 treatments (such as personal or family history of medullary thyroid carcinoma), or are comfortable with dietary fat restriction and potential gastrointestinal side effects. It's particularly appropriate for individuals seeking lower-cost options or those with BMI in the 28-30 kg/m² range where injectable treatments may not be first-line.

Ozempic and similar GLP-1 treatments are typically considered for patients with higher BMI (≥30 kg/m²), those with type 2 diabetes or prediabetes, or individuals who have not achieved adequate results with oral medications and lifestyle modification alone [1][2]. The greater average weight loss seen in trials makes GLP-1 agonists suitable for patients requiring more substantial reductions, though they require tolerance for injections and higher treatment costs.

Your UK prescriber at Cured Pharmacy will evaluate your medical history, current medications, weight loss goals, budget, and lifestyle preferences during the free online consultation. Factors such as cardiovascular risk, diabetes status, previous weight loss attempts, and tolerance for specific side effect profiles all influence treatment selection. Our clinical team ensures you receive evidence-based recommendations tailored to your individual circumstances, with ongoing support throughout your weight management journey.

Scientific References

  1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  2. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
  3. Torgerson, J. S., et al. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
  4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. Technology appraisal guidance [TA875]. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can I take Ozempic and Orlistat together?
Combining these medications is not standard practice and should only be done under explicit guidance from a UK prescriber. Each works through different mechanisms, but concurrent use has not been extensively studied in clinical trials and may increase side effect burden without proven additional benefit.
Is Orlistat as effective as Ozempic for weight loss?
Clinical trials show Ozempic (semaglutide) produces greater average weight loss—approximately 14.9% body weight compared to Orlistat's 5-10% over similar timeframes. However, effectiveness depends on individual response, adherence, and lifestyle factors; some patients achieve excellent results with Orlistat when combined with low-fat dietary changes.
Do I need a prescription for Orlistat in the UK?
Orlistat 120mg requires a prescription from a UK-registered prescriber. Lower-dose Orlistat 60mg (brand name Alli) is available over-the-counter from pharmacies, though prescription-strength 120mg provides greater fat-blocking efficacy and is recommended for most patients seeking significant weight loss.
How quickly will I see results with Orlistat vs Ozempic?
Orlistat users typically notice weight loss within 2-4 weeks when adhering to a low-fat diet, with maximum effects by 6 months. Ozempic users often see appetite suppression within days, with progressive weight reduction over 12-16 weeks as doses are titrated upward. Both require sustained adherence for optimal long-term outcomes.
Can I get an ozempic vs orlistat uk prescription online at Cured Pharmacy?
Yes. Our UK-registered prescribers provide free online consultations for both Orlistat and GLP-1 weight loss treatments including Wegovy and Saxenda. Complete the 3-minute assessment, and our clinical team will recommend the most suitable option based on your medical history, with discreet home delivery available across the UK.
What happens if I eat high-fat foods while taking Orlistat?
Consuming meals with more than 15g fat while on Orlistat significantly increases the risk of gastrointestinal side effects including oily stools, faecal urgency, and flatulence with discharge. These symptoms are not dangerous but can be uncomfortable and socially inconvenient, making dietary fat restriction essential for tolerability.
Is Ozempic licensed for weight loss in the UK?
Ozempic (semaglutide) is licensed by the MHRA for type 2 diabetes management. Wegovy contains the same active ingredient (semaglutide) at higher doses and is specifically licensed for chronic weight management in adults with BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities.
Which is safer: Orlistat or Ozempic?
Both medications have well-established safety profiles when prescribed appropriately. Orlistat's side effects are primarily gastrointestinal and manageable with dietary modification. Ozempic carries rare risks including pancreatitis and thyroid concerns, requiring thorough medical screening. Your UK prescriber will assess your individual risk factors to determine the safest option for your circumstances.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.